Quick Answer
RenovoRx, Inc. reported Gross Profit of $796.0 thousand for the year ending 2025.
- RenovoRx, Inc. showed an increase of +1,751.2% in Gross Profit from 2024 to 2025.
- This data is from RenovoRx, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $103.0 thousand | Q2 2025: $270.0 thousand | Q3 2025: $213.0 thousand.
- Historical annual values: Fiscal year 2025: $796.0 thousand | Fiscal year 2024: $43.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: